LEADERS IN SPY FLUORESCENCE IMAGING
NOVADAQ ANNOUNCES FIRST QUARTER 2017 FINANCIAL RESULTS
NOVADAQ to Report First Quarter 2017 Financial Results on May 3, 2017
SPY Elite and DermACELL: Advancing Immediate Pre-Pectoral Breast Reconstruction Techniques
- Dr. Pittman
- Dr. Chang
SPY Elite and DermACELL: Bridging the Gap between Breast and Plastic Surgeons to Improve Breast Reconstruction
- David Weintritt, M.D.
- Mark Venturi, M.D.
Imaging is everything.
With over 15 years leading development in SPY Fluorescence Imaging Technology, our global mission is to enable physicians with point-of-care imaging solutions that provide real time clinically significant and actionable information to improve care quality and lower healthcare costs.
N = 1
For more than a decade, the use of one technology - SPY Fluorescence - continues to positively impact the lives of doctors and patients across the globe.
One Solution, Multiple Applications
SPY Fluorescence Imaging Technology has been proven across multiple specialties, and has been demonstrated as beneficial in over 75 different surgical applications.
Peer-Reviewed Proven Results
More than 235 peer-reviewed publications demonstrate that the use of SPY Fluorescence Imaging Technology during complex surgery and diagnostic procedures, leads to lower rates of post-operative complications and lower hospital costs.
SPY Fluorescence Imaging
Explore the world of NOVADAQ's SPY Fluorescence Imaging TechnologyInteractive Media